|
Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection Clinical research trials and Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection. Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection
Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection
For Condition: HIV Infections,HIV Seronegativity
Status: Completed
Sponsor(s): VaxGen ,
Synopsis: The purpose of this study is to see if an HIV vaccine, AIDSVAX B/B, can protect adults who are at risk from becoming infected with HIV. Patients who become infected despite immunization will be studied to see if receiving the vaccine before becoming infected will help keep HIV levels (viral load) low.
Details: Volunteers receive 7 blinded, intramuscular vaccinations (at Months 0, 1, 6, 12, 18, 24, 30) containing either the AIDSVAX B/B vaccine or a placebo (aluminum adjuvant only). Volunteers are randomized in a 2 to 1 vaccine-to-placebo ratio. HIV-uninfected persons are followed for a total of 16 visits beginning at screening and continuing until Month 36. Patients who become HIV infected during study are followed every 4 months for at least 24 months.
Eligibility:
Study Type: Interventional, Prevention, Double-Blind, Safety Study
Minimum Age/Maximum Age: 18 Years/60 Years
Genders: Both
Protocol Entry Criteria: Exclusion Criteria You will not be eligible for this study if you: - Use injection drugs. - Have a history of any serious diseases or conditions, including lymphoma. - Have ever received an HIV vaccine. - Have taken post-exposure treatment to prevent HIV infection within 4 weeks prior to study entry. - Are planning to take other HIV vaccines during this study. - Are pregnant. - Have taken certain medications or received certain therapies, including chemotherapy and radiation. - Have received certain vaccines within 2-4 weeks prior to study entry. You may be eligible for this study if you: - Are HIV-negative. - Are between 18 and 60 years old. - Are available for 3 years of follow-up. - Agree to use effective methods of birth control during the study and for 90 days after. - Are one of the following: - A woman who is currently in a sexual relationship with an HIV-positive man. - A woman who has had more than one male partner and at least one sexually transmitted disease (STD) within the past 12 months. - A man who has sex with men and has had anal intercourse within the past 12 months. (You will not be eligible if you have been in the same relationship with only one HIV-negative man for at least 12 months.)
Total Enrollment: 5000
Location and Contact Information:
Univ of Illinois at Chicago / Dept of Medicine
Chicago, Illinois, 60612
United States
Miriam Hosp
Providence, Rhode Island, 02906
United States
Research and Education Group
Portland, Oregon, 97210
United States
Abbott Northwestern Hosp
Minneapolis, Minnesota, 55407
United States
Wellness Ctr / Las Vegas
Las Vegas, Nevada, 89102
United States
Howard Brown Health Ctr
Chicago, Illinois, 60613
United States
Hennepin County Med Ctr
Minneapolis, Minnesota, 55415
United States
Univ of Washington
Seattle, Washington, 98104
United States
Univ of Texas Med Branch Ctr for Clinical Studies
Galveston, Texas, 77555
United States
Phoenix Body Positive
Phoenix, Arizona, 85016
United States
Dutchess County Dept of Health
Poughkeepsie, New York, 12601
United States
PW Clinical Research / LLC
Winston Salem, North Carolina, 27103
United States
Boulevard Comprehensive Care Ctr
Jacksonville, Florida, 32209
United States
Saint Louis Univ Hosp / Ctr for Vacc Dev
St. Louis, Missouri, 63104
United States
Mount Sinai Med Ctr / Jack Martin Fund Clinic
New York City, New York, 10029
United States
Mem Hosp of Rhode Island
Pawtucket, Rhode Island, 02860
United States
Ctr Hosp de Universite de Montreal (CHUM)
Montreal, Quebec,
Canada
Case Western Reserve Univ
Cleveland, Ohio, 44106
United States
Univ of Rochester Med Ctr
Rochester, New York, 14642
United States
Omega Med Research
Providence, Rhode Island, 02907
United States
New York Blood Ctr
Bronx, New York, 10456
United States
Clinical Pharmaceutical Trials Inc / St Johns Doctors Bldg
Tulsa, Oklahoma, 74104
United States
Nelson Tebedo Health Resource Ctr
Dallas, Texas, 75219
United States
Palm Beach Research Ctr
West Palm Beach, Florida, 33409
United States
Univ of Pittsburgh Med School
Pittsburgh, Pennsylvania,
United States
AIDS Research Alliance
West Hollywood, California, 90069
United States
Univ of Alabama at Birmingham
Birmingham, Alabama, 35294
United States
Clinical Research of Puerto Rico Inc
San Juan, , 00909
Puerto Rico
Univ of New Mexico Hlth Sciences Ctr / Dept of Med
Albuquerque, New Mexico, 87131
United States
St Pauls Hosp
Vancouver, British Columbia,
Canada
Univ of California - Davis Med Ctr / CARES
Sacramento, California, 95817
United States
AIDS Services Erie County Med Ctr
Buffalo, New York, 14215
United States
UTMB Ctr for Clinical Studies / St John Prof Bldg
Houston, Texas, 77058
United States
AIDS Research Consortium of Atlanta
Atlanta, Georgia, 30308
United States
New York Univ Med Ctr / Dept of Environmental Med
New York City, New York, 10016
United States
UCSF - San Francisco Gen Hosp
San Francisco, California, 94110
United States
IDC Research Initiative
Altamonte Springs, Florida, 32701
United States
New Jersey Community Research Initiative
Newark, New Jersey, 07103
United States
Louisiana State Univ Med Ctr / Infect Diseases
New Orleans, Louisiana, 70112
United States
Univ of Hawaii
Honolulu, Hawaii, 96816
United States
San Francisco Gen Hosp
San Francisco, California, 941102859
United States
Park Nicollet Med Ctr / Hlth Education
St. Louis Park, Minnesota, 55416
United States
Community AIDS Resource Inc
Coral Gables, Florida, 33146
United States
Oak Lawn Physicians / North TX Ctr for AIDS & Cln Rsch
Dallas, Texas, 75219
United States
Project Achieve - New York Blood Ctr - Women only
Bronx, New York, 10456
United States
Santa Clara Public Health Dept
San Jose, California, 95128
United States
Johns Hopkins Univ / Ctr for Immun Rsch
Washington D.C., District of Columbia, 20003
United States
ViRx Inc
Palm Springs, California, 92262
United States
Philadelphia FIGHT
Philadelphia, Pennsylvania, 19017
United States
Community AIDS Resource Inc
Riviera Beach, Florida, 33404
United States
Nalle Clinic / Clinical Research Dept
Charlotte, North Carolina, 28207
United States
Wisconsin AIDS Research Consortium
Milwaukee, Wisconsin, 53203
United States
Fenway Community Health Ctr
Boston, Massachusetts, 02115
United States
Community Hosp Indianapolis
Indianapolis, Indiana, 46219
United States
Community AIDS Resource Inc
Ft. Lauderdale, Florida, 33308
United States
Denver Hlth and Hosp Authority / Dept of Pub Hlth
Denver, Colorado, 80204
United States
Municipal Health Service
Amsterdam, ,
Netherlands
St Paul Public Health
St. Paul, Minnesota, 55101
United States
Kansas City AIDS Research Consortium
Kansas City, Missouri, 64111
United States
Univ of California / UCI Med Ctr
Orange, California, 92868
United States
Infectious Disease Research Institute
Tampa, Florida, 33614
United States
Ohio State Univ / ACTU-Univ Clinic
Columbus, Ohio, 43210
United States
San Francisco Dept of Hlth / AIDS Office
San Francisco, California, 94102
United States
St Luke Roosevelt Hosp
New York City, New York, 10011
United States
Arizona Clinical Research Ctr Inc
Tucson, Arizona, 85712
United States
Chicago Ctr for Clinical Research
Chicago, Illinois, 60610
United States
Albany Med College / Div of HIV Medicine
Albany, New York, 12208
United States
Additional Information:
Study ID Numbers: VAX 004;
Study Start Date:
Record last reviewed: January 2000
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002441
Other Hiv Infections Studies:
1. Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults
2. The Safety and Effectiveness of 524W91
3. A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients
4. An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score > 40 Percent and < 100 Percent
5. Effects of home visits on medication adherence in children and youth with HIV
Related Studies:
Other HIV Infections Clinical Trials
Other Wisconsin Clinical Trials
Other Milwaukee Clinical Trials
Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection
|
|
|
|
|
|
|
|